Next Article in Journal
Improvement of Peptidyl Copper Complexes Mimicking Catalase: A Subtle Balance between Thermodynamic Stability and Resistance towards H2O2 Degradation
Next Article in Special Issue
A Literature Review of Artocarpus lacucha Focusing on the Phytochemical Constituents and Pharmacological Properties of the Plant
Previous Article in Journal
Comparative Study of the Potentially Toxic Elements and Essential Microelements in Honey Depending on the Geographic Origin
Previous Article in Special Issue
Antifungal and Cytotoxic Activity of Diterpenes and Bisnorsesquiterpenoides from the Latex of Euphorbia resinifera Berg
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 17
10.3390/molecules27175475
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food Ingredients as Complementary and Alternative Therapies for Atopic Dermatitis-A Comprehensive Review

by
Yik-Ling Chew
1,*,
Mei-Ann Khor
1,
Zhao Xu
1,
Sue-Kei Lee
1,
Jing-Wen Keng
1,
Sze-Huey Sang
1,
Gabriel Akyirem Akowuah
1,
Khang Wen Goh
2,
Kai Bin Liew
3 and
Long Chiau Ming
4
1
Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia
2
Faculty of Data Science and Information Technology, INTI International University, Nilai 71809, Malaysia
3
Faculty of Pharmacy, University of Cyberjaya, Cyberjaya 63000, Malaysia
4
PAP Rashidah Sa’adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(17), 5475; https://doi.org/10.3390/molecules27175475
Submission received: 30 June 2022 / Revised: 14 August 2022 / Accepted: 19 August 2022 / Published: 26 August 2022
(This article belongs to the Special Issue Biological Activities of Traditional Medicinal Plants)
Browse Figures
Versions Notes

Abstract

:
Traditional medicine is critical in disease treatment and management. Herbs are gaining popularity for disease management and treatment. Therefore, they can be utilised as complementary and alternative treatment (CAT) ingredients. Atopic dermatitis (AD) is one of the common non-communicable diseases. It is characterised by chronic inflammatory skin disease with intense pruritus and eczematous lesions. AD is associated with oxidative stress, microbial infection, and upregulation of inflammatory cytokines. Both children and adults could be affected by this skin disorder. The prevalence of AD is increasing along with the country’s level of development. This review revisited the literature on four medicinal herbs widely used as complementary medicine to manage AD. These therapeutic herbs are commonly eaten as food and used as spices in Asian cuisine. The four food herbs reviewed are Cassia alata, Coriandrum sativum, Curcuma longa Linn, and Azadirachta indica. Their traditional uses and phytochemical content will be covered. Four relevant pharmacological and biological activities of the plants crucial in AD management have been reviewed and discussed, including anti-inflammatory, anti-microbial, antioxidant, and wound recovery.

1. Introduction

Atopic dermatitis (AD) is a chronic inflammatory skin disorder that affects a particular population worldwide. It is characterised by pruritic, erythematous, scaly papules, vesicles, and plaques that might continue as chronic lichenified lesions caused by water loss through the epidermis, intense itching, and cutaneous inflammation [1,2]. The severe itching will cause excessive scratching, and it may cause an open wound. The skin of an AD patient has an altered skin microbiome, mainly colonised by Staphylococcus aureus. Skin infection happens when the microorganism enters the body via an open wound. Furthermore, excessive free radicals would mediate lipid peroxidation, leading to membrane destruction.
This skin disorder affects 60–80% of patients with a family medical history of type 1 allergies, allergic rhinitis, and asthma [3,4]. The patients have an inherited tendency to produce immunoglobulin E (IgE) antibodies in response to allergens. A defective skin barrier can easily allow the allergens to enter the epidermal and cause a secondary immunologic reaction. Allergens include dust, pollen, house dust mite, air pollutants, and even food allergens [5]. These allergens are generally concurrent with allergy, asthma, and stress [6]. This skin disorder is a significant social and financial burden to the patients, their families, and the whole community [5,7].

2. Current First-Line Therapy

Topical corticosteroids are the first-line therapy for AD. Topical corticosteroids could exhibit various vital activities which are mandatory in managing AD. It is effective in controlling skin disorders, and they are also fast-acting. However, prolonged use and exposure to topical corticosteroids could induce various side effects, such as local irritation, atrophy changes, telangiectasia, striae, purpura, and stellate pseudoscars hyperpigmentation, hypopigmentation, and rosacea [8]. Luger et al. [9] reported that 95.6% of AD patients use topical corticosteroids. A total of 50% of these patients were on topical corticosteroids daily for more than a year. Many patients rely on topical corticosteroids to manage this skin disorder daily. However, patients’ continuous exposure to topical corticosteroids may lead to excessive exposure compared to the recommended dosage in clinical practice and treatment guidelines [9]. Some patients have experienced steroid withdrawal symptoms after stopping the medication after prolonged use.

3. Use of Complementary and Alternative Treatment (CAT) in AD

In recent years, AD patients have begun to seek CAT to manage AD. Patients are switching to the CAT when they realise that topical corticosteroids’ side effects are irreversible and long-term. It was reported that almost 50% of the patients used CAT to manage the disease [10] (Table 1) and favoured plant-based ingredients in CAT [11,12]. This review emphasised medicinal herbs popularly used as CAT for AD. These therapeutic herbs are commonly served as food or spices in Asian cuisine. They are Cassia alata L., Coriandrum sativum L., Curcuma longa L., and Azadirachta indica A. Juss. These four medicinal herbs are widely consumed as food and spice. Still, they have also been used traditionally among the local communities in Asia, mainly in Southeast Asian countries such as Malaysia, Thailand, Indonesia and Brunei. One of the applications among the local community is skin disease management. The traditional usage, phytochemicals, and the core pharmacological activities of these herbs in managing AD were reviewed. The phytochemicals and pharmacological activities covered are anti-inflammatory, anti-microbial, antioxidant, and wound recovery. This review has supported evidence from relevant studies on the selected herbs in the management of skin disorders.

4. Cassia alata L. (Caesalpinaceae)

Cassia alata has been used traditionally as herbal therapy for various illnesses (Figure 1). The leaves are boiled and consumed for constipation and intestinal worm treatment. They are also prepared as a paste and applied topically to manage various skin disorders, such as AD, ringworm, and white-spot fungal infections [13,14,15]. The phytochemical ingredients in C. alata flower and leaves could exhibit promising antifungal and wound healing properties [13,16,17,18,19]. C. alata consists of various phytochemicals, including alkaloids, tannins, saponins, phenols, flavonoids, anthraquinones, and cardiac glycosides [20,21,22]. Astragalin, kaempferol, kaempferol 3-O-β-glucopyranoside, kaempferol 3-O-gentiobioside, rhein, aloe-emodin, emodin, β-sitosterol, 1,5-dihydroxy-2-methylanthraquinone, physcion, alatinone, n-octacosane, α-amyrin arachidate, tetracosanol, β-sitosterol, ursolic acid, and β-sitosterol-β-D-glucoside were among the phytochemicals reported in C. alata [23,24,25,26]. These phytochemicals played a significant role in pharmacological activities.

4.1. Anti-Inflammatory

C. alata had also exhibited excellent anti-inflammatory activity in various in vitro and in vivo models (Table 2). Anti-inflammatory activity was reported in the carrageenan-induced mouse paw oedema test when the mice were fed orally with C. alata extracts [18]. The inflammatory activity was inhibited at 5 mg/20 g. This finding is supported by Lewis et al. [27]. The authors discovered that C. alata leaves inhibited the production of tumour necrosis factor-alpha (TNF-α) by immature dendritic cells in a dose-dependent manner. TNF-α is an inflammatory cytokine produced during acute inflammation. C. alata leaves consist of TNF-α inhibitors which could suppress the physiologic response to inflammatory response [7]. The suppression of inflammatory response by the inhibitors is evident in the study by Riaz et al. [26]. Astragalin from C. alata could regulate the level of the anti-inflammatory related transcription factor, enzymes, and cytokines such as TNF-α, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), matrix metalloproteinase-1 (MMP-1), MMP-3, interleukin-1β (IL-1β), IL-4, IL-6, IL-8, IL-13, and interferon-gamma (IFN-γ). Anthraquinones and flavonoids in C. alata are good anti-inflammatory agents. Various studies have reported anti-inflammatory properties. Multiple studies had been performed on the anti-inflammatory of astragalin (Table 2). Besides, kaempferol, luteolin, apigenin, naringenin, rhein, chrysophanol, aloe-emodin, emodin and caffeic acid could also exhibited anti-inflammatory activity. The anti-inflammatory activity was targeted via various pathways: kaempferol inhibits the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kβ), mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) [28,29,30,31]; luteolin regulates the expression of NF-kβ, MAPK, signal transducer and activator of transcription 3 (STAT-3), iNOS, and COX-2 [32,33,34,35]; emodin suppresses IgE-mediated activation of mast cells, NF-kβ, and MAPK [36,37,38]; Aloe-emodin and apigenin inhibits iNOS, COX-2, protein kinase C, ERK, MAPK, NF-kβ, Janus kinase (JAK), c-Jun N-terminal kinases (JNK), and STAT-3 [35,39,40,41,42].
Many other related anti-inflammatory studies of C. alata using various in vitro and in vivo models were summarised in Table 2. Therefore, this plant is believed to inhibit the skin inflammatory response in AD effectively.

4.2. Antimicrobial

C. alata exhibits good antibacterial and antifungal activities toward a broad spectrum of pathogenic microorganisms [43]. These pathogenic microorganisms could cause severe skin infections and complications. Examples of bacteria that were susceptible to C. alata were S. aureus (including methicillin-resistant S. aureus (MRSA)), Escherichia coli, Streptococcus pyogenes, Bacillus subtilis, Pseudomonas aeruginosa, Proteus mirabilis, and Vibrio cholerae [20,44,45]. A recent study revealed that 9-octadecenoic acid methyl ester from C. alata leaves is a potent anti-microbial agent against MRSA [45]. The skin of AD patients is often over-colonised by bacteria, especially S. aureus [46]. Although S. aureus is a commensal inhabitant of the human skin, this bacterium could cause severe skin infection if it breaches the defective skin barrier and wound. It produces exotoxins with superantigenic properties. These exotoxins could lead to adverse effects on cell function and induce cell death.
The colonisation of S. aureus on atopic skin should be adequately controlled with anti-microbial agents to reduce skin inflammation. C. alata is effective in AD management because it inhibits the growth of S. aureus on the skin, reducing skin inflammation [20]. Topical treatment of skin inflammation with C. alata, like what has been used traditionally, showed that the skin conditions improved significantly. It has been proven by Breuer et al. [46], who discovered that 90% of the patients treated with anti-microbial agents, specifically targeting S. aureus, had a lower SCORing Atopic Dermatitis (SCORAD) score. A recent study revealed that the diethyl ether fraction of C. alata leaves was the most potent fraction against MRSA, eluted from column chromatography. The authors performed fractionation, and the antibacterial activity of the fractions was screened using the agar overlay method. The active spot was analysed using the gas chromatography-mass spectrometry (GC-MS) method. The spectrum has shown that the anti-microbial compound is 9-octadecenoic acid methyl ester [45].
The anti-microbial activity of the phytochemicals in C. alata, particularly towards S. aureus, was studied. Phenolic acids, flavonoids and anthraquinones in C. alata could exhibit promising anti-microbial activity. For instance, kaempferol and aloe emodin showed excellent anti-microbial activity toward multidrug-resistant S. aureus (MIC50 13.0 ± 1.5 μg/mL and 12.0 ± 1.5 μg/mL, respectively). In comparison, kaempferol 3-O-β-glucopyranoside and kaempferol 3-O-gentiobioside exhibited less potent activity (MIC50 83.0 ± 0.9 μg/mL and 560.0 ± 1.2 μg/mL, respectively) [1]. Hazni et al. reported that the free hydroxyl group at the C-3 position of kaempferol and its derivatives is essential in exhibiting anti-microbial activity. The size of the R1 group of the kaempferol derivatives would also affect the anti-microbial potency. The bigger the size of the group at the R1 position, the weaker the anti-microbial potency [1]. Gallic acid, caffeic acid, cannabinoid dronabinol, rhein and fatty acids in the leaves and seeds could also exhibit antibacterial activity against S. aureus [2,3,4,5].
Quercetin could also exhibit potent antibacterial activity. The activity is due to the multiple hydroxyl groups in the chemical structure [6,7,8,9], which could affect the peptides, proteins and ion channels in the bacterial membrane [8,10]. It could also disrupt the cell wall, weaken the bacteria cell membrane integrity and cause cell apoptosis [11]. Rhein could also exhibit potent antibacterial activity against S. aureus (MIC 4 µg/mL; MIC90 8 µg/mL). It regulates the expression of transporter genes [12], changes the biological mechanism in the bacteria, such as inhibiting the aerobic and anaerobic respiration of bacteria and regulates the metabolism of the amino acid.
In addition, C. alata could also exhibit good anti-microbial action against pathogenic fungi related to skin disorders, including dermatophytes, such as Aspergillus niger, A. flavus, A. candidus, Penicillium patulum, Candida albicans, Rhizopus stolonifera, Trichophyton mentagrophytes var interdigitale, T. mentagrophytes var. mentographytes, T. rubrum, Microsporum gypseum and M. canis [47,48]. Therefore, the anti-microbial activity of C. alata has contributed significantly to skin disease management and is a prominent candidate in CAT.

4.3. Antioxidant

A high level of oxidative stress and reduction in antioxidants in the body system are important contributing factors in the pathogenesis of AD [49]. C. alata is rich in polyphenols which could exhibit strong scavenging activity against free radicals and oxidative agents, such as nitric oxide, hydrogen peroxide, superoxide anion, 1, 1-diphenyl-2-picrylhydrazyl (DPPH), and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)(ABTS) free radicals [47,50,51,52,53]. For instance, the extract inhibited 50% of the DPPH free radical at 2.25 ± 0.28 μg/mL. Its DPPH free radical scavenging activity was more potent than ascorbic acid (IC50 = 3.99 ±0.09 μg/mL) and Trolox (IC50 = 4.50 ±0.08 μg/mL) [13]. Besides free radical scavenging, it could exhibit good reducing power and lipid peroxidation inhibition effects [50,51]. Patients with AD usually will have higher serum malondialdehyde (MDA) levels. MDA is an oxidant provided by xanthine oxidase, which could cause lipid peroxidation. Redox imbalance due to excessive oxidative stress could also mediate the pathogenesis. A reduction in MDA was noticed in the Xanthine–Xanthine oxidase system, as reported by Sagnia et al. [52]. It was explained that the reduction in MDA was correlated with the reducing power. Phenolic and flavonoid content of the extract could exhibit good reducing power and hydrogen donation ability, and they play an important role in AD management. In a recent pilot clinical study, Sikora et al. developed a comprehensive, hydrating topical antioxidant product with C. alata and tested its efficacy on human [54]. Results showed that the product could protect the skin against induced oxidative stress due to exposure to harmful ultra-violet rays, due to the presence of water-soluble, enzymatic, and lipid-soluble antioxidants [54].

4.4. Wound Healing

Itching and redness are common signs of AD. Sometimes tiny bumps, blisters, or vesicles are noticed, and the skin is usually swollen. The itching on the skin would lead to excessive scratching, which may cause the skin to break and expose the open wounds. Local tissue damage will occur when the microorganism invades a wound and proliferates. The wound healing will also be disrupted.
Topical treatment with plant bioactive possesses wound recovery properties that would facilitate wound closure and recovery. C. alata was found could promote significant wound recovery [55]. An in vivo study by Kanedi et al. [56] showed the application of C. alata on an opened wound could reduce the epithelialisation period from 22 days to 16 days. The authors noticed that wounds inoculated with T. rubrum would require longer epithelialisation. However, anti-microbial agents in C. alata leaves could fasten wound recovery and epithelialisation. The wound recovery process was faster, and the epithelialisation period was shortened up to 27%. The size of the wound in the animal model was also reduced significantly. This result showed that the phytochemicals in the plant accelerated the wound healing process. One reason reported was that the inhibition of microbial infection promoted the epithelialisation process [57,58].
Alkaloids, terpenoids, flavonoids, anthraquinone and tannins could modulate wound closure. Oleic acid and linoleic acid could modulate the inflammatory responses in tissue repair, inhibit leukocytes and cationic serine protease activity, regulate the expression of metalloproteinase, and promote angiogenesis and collagen synthesis in wound recovery [13]. Wound healing is also closely associated with the anti-microbial activity of C. alata. 3,4- dihydroxycinnamic acid in C. alata has a broad spectrum of antibacterial activity, where it can fight Gram-positive and Gram-negative bacteria. These factors favour the healing process of wounds in patients [14].

5. Coriandrum sativum (Apiaceae)

C. sativum, commonly known as coriander, is a common herb (Figure 2). It is known as Jintan, ketumar, ketumbar, penjilang, wansui in Southeast Asia [59]. C. sativum is regularly consumed as spice and seasoning in local cuisines. However, it is also used in traditional medicine, where the plant is used to treat measles, indigestion, worm infections, rheumatism, pain in joints [60,61], and various skin disorders such as eczema, pimples, blackheads, dry skin, and skin ulcers [62,63,64,65]. It was reported that this plant could exhibit carminative, diuretic, tonic, stomachic, antibilious, anticatarrhal, antispasmodic, galactagogue, emmenagogue, and aphrodisiac properties [59].
C. sativum is rich in essential and fatty oils, 0.03–2.5% and 9.9–27.7%, respectively. S-(+)-linalool is the major essential oil in this plant. Other essential and fatty oil present include monoterpenes hydrocarbons viz. α-pinene, limonene, γ-terpinene, p-cymene, borneol, citronellol, camphor, geraniol and geraniol acetate, heterocyclic components like pyrazine, pyridine, thiazole, furan and tetrahydrofuran derivatives, isocoumarins, coriandrin, dihydrocoriandrin, coriandronsA-E, flavonoids, pthlides, neochidilide, digustilide phenolic acids, and sterols. The composition of essential oil in C. sativum was tabulated in Table 3.

5.1. Anti-Inflammatory

Significant anti-inflammatory activity had been reported in C. sativum, where it could alleviate contact dermatitis in the animal model. Sonika et al. [67] studied the anti-inflammatory activity of C. sativum ethanolic extract using carrageenan-induced rat paw oedema. A total of 40.81% oedema inhibition was reported in mice fed orally with a 200 mg/kg extract. Similar findings were also reported by Reuter et al. [62]. The authors noted that the anti-inflammatory activity of C. sativum was exhibited by a major fatty acid, linalool (65–75% in oil composition). It could regulate inflammatory mediators such as IgE, TNF-α, IFN-γ, IL-1, IL-4, and IL-13 [68,69]. In addition, it was found that C. sativum could reduce IL-6 [69]. A recent review by Malek Mahdavi and Javadivala [69] critically reviewed the anti-inflammatory activity reported in C. sativum, primarily focused on IL-1β, IL-6, and TNF-α. Various research using the in vitro and in vivo models agreed that C. sativum could exhibit promising anti-inflammatory activity. The expression of IL-1β, IL-6, and TNF-α was suppressed or lowered upon treatment with C. sativum extract, oil, and fractions. The suppression of inflammatory mediators was shown in the in vitro models such as lipopolysaccharide (LPS)-stimulated neutrophils [70], LPS-induced BV-2 microglia cells [71], LPS-stimulated RAW264.7 macrophage cells [72,73], and human bronchial epithelial cells [74]. The anti-inflammatory activities of C. sativum had also been investigated using various in vivo models. For instance, Freund’s adjuvant (CFA)-induced arthritic rats [75,76,77], ischemia/reperfusion injury (IRI) rats [78], and streptozotocin (STZ)-induced diabetic mice and rats [79,80]. However, none of the in vitro and in vivo models studied could be correlated with AD. The anti-inflammatory using AD models should be investigated.
The regulation of inflammatory mediators is critical in managing skin inflammation. Besides, it could also exhibit promising anti-microbial activity toward the S. aureus colonised on the skin [53].

5.2. Anti-Microbial

Numerous studies have reported on the anti-microbial activity of C. sativum. Linalool and coriander oil exhibited strong anti-microbial activity towards yeast, Gram-positive, and Gram-negative bacteria. Its activity was more potent than phenol. The inhibition activity against Gram-positive bacteria was two times stronger. In addition, the activity was 1.5 times more potent against yeast and Gram-negative bacteria [81]. Linalool in coriander could exhibit a broad spectrum of anti-microbial activity towards numerous microbial, including S. aureus, Salmonella typhimurium, Listeria monocytogenes, Serratia grimesii, Enterobacter agglomerans, Yersinia enterocolitica, B. cereus, B. megaterium, Klebsiella pneumoniae, P. aeruginosa, E. coli, E. cloaca, and Enterococcus faecalis [82,83]. Besides being an anti-microbial agent for skin disorders, coriander oil is also a penetration enhancer. It could alter the conformational domain of the skin and enhance transdermal drug delivery. Therefore, it could be added to the topical formulation for skin disease management and inhibit the skin microbial that cause skin infection.

5.3. Antioxidant

Numerous studies reported that the polyphenols, flavonoids, and terpenoids in C. sativum exhibited strong free radical scavenging and lipid peroxidation inhibition activities [61,84,85,86]. Twenty-one antioxidant compounds were reported in the recent study by Msaada et al. [87]. The compounds identified were mainly phenolic acids and flavonoids. The phenolic acids present were gallic, chlorogenic, caffeic, vanillic, p-coumaric, ferulic, rosmarinic, o-coumaric, trans-hydroxycinnamic, salicylic, and trans-cinnamic acids; while the flavonoids reported were quercetin-3-rhamnoside, rutin trihydrate, luteolin, quercetin dihydrate, resorcinol, kaempferol, naringin, apigenin, flavone, and coumarin. Chlorogenic acid and gallic acid are the major compounds present in C. sativum. It is rich in essential oils. Chlorogenic acid, gallic acid and essential oils could exhibit good to moderate antioxidant activity [88]. Hajlaoui et al. [89] recently studied the anti-microbial activity of the essential oil extracted from C. sativum. The essential oil could exhibit moderate DPPH scavenging (IC50 = 38.83 ± 0.70 µg/mL), superoxide anion scavenging (IC50 = 37.00 ± 1.73 µg/mL), reducing power (EC50 = 24.00 ± 1.53 µg/mL) and β-carotene bleaching (IC50 = 25.70 ± 1.02 µg/mL) activities. Other studies also support the free radical scavenging activity of coriander oil. Shahwar et al. [90] and Kačániová et al. [86] reported that the coriander oil could inhibit more than 50% of the free radicals in the assay. The essential oil could also exhibit chelating activity (EC50 = 70.00 ± 0.81 µg/mL) [89].

5.4. Wound Healing

Excessive scratching may cause the patches of skin to become red and scaly. Sometimes, an open wound will form. C. sativum has traditionally been used for wound healing due to its antiseptic and anti-microbial properties. It had been reported that C. sativum showed promising wound healing effects in second-degree burn wounds in the rat model. Zadeh et al. [91] studied the effect of wound healing cream formulated with coriander extract. The effects were compared with silver sulfadiazine cream and Vaseline gauze dressing applied to the burn wound in the rat. The results showed that the wound in the rats improved significantly. The authors explained that this was due to fatty acids, which could exhibit anti-inflammatory and anti-microbial activities. The fatty acids which exhibit prominent biological activities, such as oleic acid, linoleic acid, and palmitic acid, could effectively promote wound healing [92]. They accelerated tissue repair mechanisms by modulating the cellular response, increasing the migration of endothelial cells, and inducing angiogenesis at the wound site [93]. Consequently, the wound healed faster.

6. Curcuma longa Linn (Zingiberaceae)

C. longa, often known as turmeric (Figure 3), is commonly used as a spice in Asian cuisine [94]. The plant has various common name in different locations, i.e., Curcuma (Sp. It. Fr.), acafrao da India (Portugal), geelwortel (Dutch), kurkum (Arab), Manjano (East Africa [KiSwahili]), manjal (Tamil), kunyit (Indonesia), temu kunyit (Asian), and huang jiang (Chinese). The ethnomedicinal use of C. longa has been known for years. It has been well documented in various literature due to its antioxidant, anti-inflammatory, antimutagenic, anti-microbial, and anticancer properties [95,96].
C. longa is commonly used in Ayurvedic and Unani systems of medicine [97]. In Ayurveda, fresh turmeric is processed into a paste to treat common eye infections, applied on a wound as a dressing, and treat bites, burns, acne, and various skin diseases. Turmeric milk with honey is consumed to reduce inflammation, and health maintenance, improve memory, prevent heart diseases, reduce the risk of cancer, regulate blood sugar levels, and many more. The poultice of turmeric is applied to the perineum to aid in healing any lacerations in the birth canal [98]. C. longa rhizome has traditionally been used in skin disorders management [83], dental diseases, dyspepsia, acidity, indigestion, flatulence, ulcers, antioxidants, antifertility, and alleviating the hallucinatory effects of hashish, and other psychotropic drugs [99].
C. longa is rich in polyphenolic curcuminoids, namely curcumin (80%), demethoxycurcumin (12%), bisdemethoxycurcumin (8%), and essential oil (5.8%) [100,101]. The essential oil which is present in rhizomes includes α-phellandrene (1%), sabinene (0.6%), cineol (1%), borneol (0.5%), zingiberene (25%), and sesquiterpenes (53%) [102]. These phytochemicals could exhibit important pharmacological activities, including anti-inflammatory, anti-microbial, antioxidant, and promote wound healing.

6.1. Anti-Inflammatory Activity

As mentioned, C. longa possesses significant anti-inflammatory activity. Curcumin in C. longa could exhibit strong anti-inflammatory action, and its potency is comparable to cortisone. It can inhibit the biosynthesis of inflammatory prostaglandins from arachidonic acid and neutrophil function during inflammatory states [103]. Prostaglandins and leukotrienes are the inflammatory mediators produced in the arachidonic acid oxygenation pathway. They contribute to common inflammatory responses, such as erythema, oedema, and pain. The reduction of prostaglandin and inhibition of leukotriene biosynthesis through the lipoxygenase pathway is crucial in controlling inflammation [104]. The inhibition activity of curcumin in the topical cream is proven effective in managing skin inflammation and allergies.
In addition, curcumin inhibits the synthesis of inflammatory-related cytokines, such as lipoxygenase (LOX), COX, phospholipases, leukotriene, prostaglandins, thromboxane, nitric oxide elastase, hyaluronidase, collagenase, monocyte chemoattractant protein-1, interferon-inducible protein, TNF-α, IL-12, IL-1α and IL-6 [105,106]. Studies have reported that curcuminoid could reduce the nitric oxide synthase in the animal model and inhibit inflammation. The amount of nitrite released into the culture medium in 24 h (IC50 = 6 µM) decreased significantly upon the treatment with curcumin. Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kB) is highly activated at the inflammation site in AD. Curcumin can inhibit NF-kB to regulate the inflammation responses [106]. It could also induce the transcription of proinflammatory cytokines and regulate the activation and differentiation of inflammatory T-cells [105]. These anti-inflammatory activities would reduce the swelling skin reaction.

6.2. Anti-Microbial Activity

AD is often associated with dermatophyte infection. Dermatophytes hydrolyse keratin from skin tissue and cause superficial infections. A recent study by Choi et al. [107] reported that 1.42% of AD patients showed positive towards dermatophytes on their skin, whereas none was detected in healthy individuals. C. longa and curcuminoids have shown promising anti-microbial activity against various dermatophytes and pathogens, including Fusarium miniformes MAY 3629, B. subtilis ATCC 6633, and F. oxysporum ATCC 48122, Plasmodium falciparum and Leishmania major, T. longifusus and Microsporum canis and S. aureus [108,109,110]. Tumeric oil extracted from the plant is commonly used as a topical oil for treatment as it could exhibit good anti-microbial activity. The anti-microbial activity of turmeric oil was exhibited by aromatic tumerone. The activity was evaluated using guinea pigs. It was found that turmeric oil could inhibit all 15 dermatophytes isolates in the in vivo model. The skin microbial was inhibited at 1:40 to 1:320 dilutions of the turmeric oil [111]. In addition, the oil could also inhibit the other pathogenic fungi at 1:40 to 1:80 dilutions. The study showed that the skin lesion disappeared after seven days post-turmeric application. Therefore, it is deduced that C. longa is effective in managing AD.
Curcumin in C. longa could also exhibit synergistic effects with other phytochemicals. Curcumin could exhibit synergistic effects with quercetin. The co-delivery of curcumin and quercetin could exhibit anti-microbial activity against MRSA at lower concentration [112]. This is in agreement with Chittasupho et al., where the combination of curcumin with quercetin would exhibit antibacterial activity against S. aureus and P. aeruginosa, but not in individual compounds [113].

6.3. Antioxidants

The hepatoprotective effect of the ethanolic extract of C. longa on thioacetamide-induced liver cirrhosis had been correlated with its antioxidant effect and free radical scavenging activities. The hepatoprotective activity is proven to be contributed by curcumin in C. longa. Curcumin could also increase glutathione levels and promote the conversion of fat-soluble toxins into water-soluble toxins. These toxins would then be eliminated via liver detoxification [114]. In addition, tetrahydrocurcumin in the aqueous extract functions as an antioxidant in C. longa [115,116]. Sugiyama et al. [117] reported that tetrahydrocurcumin is a potent antioxidant. It could exhibit strong antioxidant activity and is more potent than curcumin. It scavenges and neutralises free radicals generated during skin inflammation and oxidative stress. Oxidative stress could cause the upregulation of proinflammatory cytokines. The cytokines would lead to the release of excessive free radicals and lead to the pathogenesis of AD. Therefore, antioxidants in C. longa would downregulate the proinflammatory cytokines, reduce the oxidative stress, scavenge the free radicals released and thus facilitate the skin barrier recovery.

6.4. Wound Healing

Wound healing is essential in managing AD as the open wound allows bacteria to enter the skin, leading to bacterial infections. The effect of C. longa in wound healing activity has been proven using the excision wound model. Curcumin in C. longa has been proven to exhibit wound healing potential. The wound contraction was more significant in the treated group, and the activity was positively correlated with C. longa extract [118]. Kulac et al. [119] studied the wound healing effects of topical curcumin therapy on a burnt rat model. The results revealed that curcumin in C. longa is effective in upregulating the expression of proliferating cell nuclear antigen in the skin tissues of rats in the burnt group. Maghima et al. [120] tested the wound recovery of the metallic silver nanoparticles (AgNPs) with C. longa leaf (CL-AgNPs). The study revealed that CL-AgNPs exhibited wound healing ability on fibroblast (L929) cells. A significant increase in cell migration towards the wounded region of the damaged fibroblast cells upon the treatment with CL-AgNPs [120]. Another study also supported that C. longa-treated burn wounds took a shorter time to heal, showing significantly higher collagen deposition, vascularisation, angiogenesis, and fibrosis during the healing process [121]. Curcumin is a proangiogenic mediator which could stimulate the transforming growth factor-beta [106]. It could result in the production of extracellular matrix and angiogenesis. Angiogenesis is the process of increasing the formation of blood vessel density. A higher rate of endothelial cell proliferation showed better progress in wound repair and closure [106]. Therefore, it is believed that C. longa could manage the skin condition of AD patients by promoting the wound healing process. This repairs and restores the damaged skin barrier.

7. Azadirachta indica A. Juss. (Neem) (Meliaceae)

A. indica, commonly known as neem (Figure 4), grows in a broad region in tropical and semitropical countries such as India, Pakistan, Nepal, and Bangladesh. Neem extracts are commonly applied as complementary medicine in Ayurveda, Unani, and homoeopathy. These extracts have been reported to treat numerous skin disorders, including eczema, psoriasis, lice, ulcerated skin, and syphilitic sores [62,122].
Neem is rich in phytochemicals, and they possess valuable therapeutic functions. Various important bioactive compounds are found in multiple parts of the plant, and these phytochemicals are from triterpenes, flavonoids, limonoids, saponins, phenolic acids, and tannins. Examples of phytochemicals reported include azadirachtin, nimbolinin, nimbin, nimbidin, nimbidol, sodium nimbinate, gedunin, salannin, quercetin, nimbin, nimbanene, 6-desacetylnimbinene, nimbandiol, nimbolide, ascorbic acid, n-hexacosanol and amino acid, 7-desacetyl-7-benzoylazadiradione, 7-desacetyl-7-benzoylgedunin, 17-hydroxyazadiradione, and nimbiol. The seeds contain valuable constituents, including gedunin and azadirachtin [123]. Neem oil is also full of beneficial fatty acids. The major fatty acid present in neem oil is oleic acid (25–54%), followed by hexadecenoic acid (16–33%), stearic acid (9–24%), linoleic acid (6–16%), and a trace amount of alpha-linolenic acid and 9-hexadecanoic [124]. These fatty acids could exhibit various pharmacological activities that are extremely important in managing AD, such as antioxidant, anti-microbial, and anti-inflammatory activities.

7.1. Anti-Inflammatory

The anti-inflammatory activity could be achieved by regulating pro-inflammatory enzyme activities, including COX and LOX [123]. Chattopadhyay et al. [125] investigated the anti-inflammatory activity of neem tree extract in rats. It was found that significant anti-inflammatory activity was shown in the cotton pellet granuloma assay in the rat model at 200 mg/kg p.o. of ethanol leaves extract. Reductions in various biochemical parameters were noticed, including deoxyribonucleic acid, ribonucleic acid, lipid peroxide, acid phosphatase, and alkaline phosphatase in the rat. The extract has also been found to suppress exudate in the cotton pellet-induced model of inflammation in rats, and this showed the inflammation had been inhibited.
Another study by Mosaddek et al. [126] also supported that neem has good anti-inflammatory activity. 400 mg/kg body weight of aqueous extract of neem was given to the rats intraperitoneally once daily for seven days, one hour before the induction of paw oedema. The paw oedema was induced in the right hind paw of rats using 2% formalin in 0.9% NaCl subcutaneously. The circumferential length was measured before and after the formalin injection. The mean increase in the circumferential length of the hind paw oedema was calculated to determine the inflammatory exudative lesion and the percentage of inhibition. Authors reported that the increase in circumferential lengths was inhibited by neem extract due to its anti-inflammatory activity. Inhibition was also noticed in samples treated with the positive control, dexamethasone. After seven days of treatment, the circumferential length decreased from 15.5 ± 0.4 mm to 4.8 ± 0.3 mm for neem extract (400 mg/kg). Although the anti-inflammatory effect of neem extract was not as promising as dexamethasone (reduction from 15.5 ± 0.4 mm to 3.2 ± 0.6 mm for 0.75 mg dexamethasone), it was significantly better than the control group (reduction from 16.4 ± 0.4 mm to 9.2 ± 0.4 mm). Nimbidin and lupeol in A. indica were suggested to be one of the contributors to the anti-inflammatory activity [127]. Studies have reported that nimbidin could suppress the mechanism of action of macrophages and neutrophils associated with the inflammatory response [128].
Another investigation was conducted to study the anti-inflammatory effect of neem seed oil (NSO) on albino rats using carrageenan-induced hind paw oedema. The results revealed that NSO showed more significant inhibition of paw oedema with the increasing dose from 0.25 mL/kg body weight to 2 mL/kg body weight. At the highest amount (2 mL/kg body weight), NSO showed maximum (53.14%) inhibition of oedema at the 4th hour of carrageenan injection [129]. The finding is also supported by Ilango et al. [130]. The authors had isolated azadiradione, a triterpenoid, from the neem fruit. The anti-inflammatory activity of the fruit extract and azadiradione were determined using the carrageenan-induced paw oedema model. Significant anti-inflammatory activity was noticed at 100/mg/kg dose of the extract and azadiradione.

7.2. Anti-Microbial

Numerous studies reported that neem exhibited significant anti-microbial activity towards various bacterial and fungal strains. Anti-microbial activity of A. indica had been performed on Salmonella typhi, E. coli V. cholerae, and B. subtilis using agar well diffusion. The zone of inhibition measured was 10–17 mm [131]. Neem oil from the leaves showed a wide range of antibacterial activity against various bacterial and fungal strains, including Staphylococcus sp., E. coli, B. cereus, Proteus vulgaris, S. typhimurium, K. pneumoniae, Shigella dysenterae, F. oxysporum, A. flavus, A. fumigates, A. niger, C. albicans, Cladosporium sp., M. canis, M. gypseum, T. rubrum, T. mentagrophytes, and Penicillum notatum [124]. Patankar et al. [132] developed a hand sanitiser using neem leaf extract. The anti-microbial assays showed that it is effective against S. aureus and the antibiotic-resistant strains, which are the common bacteria causing AD. The discovery of the anti-microbial effect of neem is essential for developing new pharmaceutical products to meet the anti-microbial therapeutic needs [124]. Nimbidin, nimbin, nimbolide, Azadirachtin, gallic acid, epicatechin, catechin, and margolone had been reported to be the antibacterial compounds present [133]. The findings on the anti-microbial activity of neem are closely relevant to AD management, as this skin disorder is often associated with bacterial and fungal infection on the skin, especially when there is an open wound due to continuous scratching.

7.3. Antioxidant

Numerous antioxidants had been reported in A. indica, including gallic acid, epicatechin, catechin, and rutin [127,133]. Chronic skin inflammation is associated with the overproduction of free radicals, including reactive oxygen species, such as superoxide and hydrogen peroxide. The increase in free radicals in the cell could cause the cell to reduce in a protective capacity. It showed pathological states where the decrease in antioxidant activity could cause the weakening of the antioxidant mechanism, which could intensify the inflammatory condition of the skin [134,135]. Oxidative injury is also the fundamental mechanism that causes inflammation. The free radicals can also cause defective basement membrane associated with AD.
The antioxidant effect of neem has been studied. The total phenolic content (85.9 ± 4.0 mg gallic acid equivalent/g of plant extract), total flavonoid content (104.9 ± 5.5 mg rutin equivalent/g of plant extract), total anthocyanin content (65.3 ± 13.9 mg rutin equivalent/g of plant extract) and lipid peroxidation inhibition (50–70% inhibition at 0.2 mg/mL concentration) of the extract were evaluated and reported. [136]. The bark and leaf extracts could also exhibit promising radical scavenging activities [137]. The DPPH radical scavenging was found to increase with the increasing concentration of the extracts [134]. 70% of DPPH radical was inhibited by the leaf extract (200 µg/mL). In addition, neem also showed promising ferric ion reducing antioxidant activity (315.25 ± 23.81 mg/g), which measures the plant phytochemicals’ ability to reduce ferric ions Fe3+ to ferrous ions Fe2+.

7.4. Wound Healing

The wound healing effect of neem extract was studied using the scratch assay and excision and incision wound model in Sprague Dawley rats [138,139]. The extract demonstrated significant wound healing ability in both in vitro and in vivo models [138,139]. In the in-vitro scratch assay, the effectiveness of neem in promoting wound closure was evaluated. The thickness of the scratch was measured over 48 h, and the percentage of wound closure in keratinocytes and fibroblasts was also observed. The wound closure of keratinocytes and fibroblasts treated with neem was better than the control group. The wound closure was 85% at 24 h and almost 100% at 48% [139]. Promising wound healing activity was also noticed in the in vivo model. Up to 95% of the wound was healed on day 21, and the wound was completely healed on day 28. The wound healing ability was similar to the positive control, Himax ointment for the animal wound. The wound healing effect was significantly better than the control group, where the wound healing effect achieved only 85% on day 28 [138]. Another study by Osunwoke et al. [120] also supported that leaf extracts promote wound healing by increasing the inflammatory response and neovascularisation [140]. A significant percentage of wound contraction, fibroblast and blood vessel count were observed. No hypertrophic scars were noticed in the wound. The neovascularisation could increase wound tensile strength and promote healing [140]. The aqueous neem leaves extract also been studied on the wound healing effect in psoriasis skin disorder in patients. In the double-blind clinical trial, the patients with psoriasis were subjected to neem leaves extract treatment. The wound healing effect of neem was shown to be effective compared to the placebo group. It was reported that β-sitosterol in A. indica aid in wound healing. These findings would support the open wound in AD due to excessive scratching to heal effectively.

8. Conclusions

CAT is an essential practice in the country to improve the health and well-being of people. It has risen in the past decade, and many patients opt to visit CAT professionals. Herbs, herbal materials, preparations, and finished herbal products containing active ingredients, plant materials, extracts, or combinations are commonly used to manage skin disorders. Herbal medicine usage is popular among individuals and primary health care providers, such as traditional medicine practitioners. This niche area will become an essential component in integrative medicine that will improve health and quality of life with modern treatments.

Author Contributions

Y.-L.C., K.B.L., M.-A.K. and Z.X. original draft preparation. Y.-L.C., K.B.L. and L.C.M. writing—review and editing. S.-K.L., J.-W.K., S.-H.S., G.A.A. and K.W.G. review and correction. All authors have read and agreed to the published version of the manuscript.

Funding

The authors would like to acknowledge the support of the Fundamental Research Grant Scheme (FRGS) (FRGS/1/2021/STG02/UCSI/02/1) and UCSI University Pioneer Scientist Incentive Fund (PSIF) research grant (Grant no.: Proj-2019-In-FPS-020).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare that they have no conflict of interests.

References

  1. Hanifin, J.; Gupta, A.K.; Rajagopalan, R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br. J. Dermatol. 2002, 147, 528–537. [Google Scholar]
  2. Weissler, A. Atopic Dermatitis–A New Dawn. Physician Assist. Clin. 2016, 1, 661–682. [Google Scholar]
  3. Eichenfield, L.F.; Tom, W.L.; Chamlin, S.L.; Feldman, S.R.; Hanifin, J.M.; Simpson, E.L.; Berger, T.G.; Bergman, J.N.; Cohen, D.E.; Cooper, K.D.; et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. J. Am. Acad. Dermatol. 2014, 70, 338–351. [Google Scholar]
  4. Reitamo, S.; Rustin, M.; Ruzicka, T.; Cambazard, F.; Kalimo, K.; Friedmann, P.S.; Schoepf, E.; Lahfa, M.; Diepgen, T.L.; Judodihardjo, H.; et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J. Allergy Clin. Immunol. 2002, 109, 547–555. [Google Scholar]
  5. Chew, Y.-L.; Al-Nema, M.; Ong, V.W.-M. Management and treatment of atopic dermatitis with modern therapies, complementary and alternative medicines: A review. Orient. Pharm. Exp. Med. 2018, 18, 67–76. [Google Scholar]
  6. Kim, K.H. Overview of atopic dermatitis. Asia Pac. Allergy 2013, 3, 79–87. [Google Scholar]
  7. Guo, Y.; Sakulnarmrat, K.; Konczak, I. Anti-inflammatory potential of native Australian herbs polyphenols. Toxicol. Rep. 2014, 1, 385–390. [Google Scholar]
  8. Coondoo, A.; Phiske, M.; Verma, S.; Lahiri, K. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol. Online J. 2014, 5, 416. [Google Scholar]
  9. Luger, T.A.; Lahfa, M.; Fölster-Holst, R.; Gulliver, W.P.; Allen, R.; Molloy, S.; Barbier, N.; Paul, C.; Bos, J.D. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis. J. Dermatol. Treat. 2004, 15, 169–178. [Google Scholar]
  10. Koo, K.; Nagayah, R.; Begum, S.; Mahmood, T.M.T.; Shah, N.M. The use of complementary and alternative medicine in children with atopic eczema at a tertiary care centre in Malaysia. Complement. Ther. Med. 2020, 49, 102355. [Google Scholar]
  11. Goh, Y.-Y.; Keshavarzi, F.; Chew, Y.L. Prevalence of atopic dermatitis and pattern of drug therapy in malaysian children. Dermatitis 2018, 29, 151–161. [Google Scholar]
  12. Zubair, M.; Rizwan, K.; Rashid, U.; Saeed, R.; Saeed, A.A.; Rasool, N.; Riaz, M. GC/MS profiling, in vitro antioxidant, anti-microbial and haemolytic activities of Smilax macrophylla leaves. Arab. J. Chem. 2017, 10, S1460–S1468. [Google Scholar]
  13. Globinmed. Senna alata (L.) Roxb. 2016 [Updated 23 June 2020]. Available online: https://www.globinmed.com/index.php?option=com_content&view=article&id=106145:senna-alata-l-roxb&catid=286&Itemid=357 (accessed on 23 June 2021).
  14. Palanichamy, S.; Nagarajan, S. Antifungal activity of Cassia alata leaf extract. J. Ethnopharmacol. 1990, 29, 337–340. [Google Scholar]
  15. Pieme, C.A.; Penlap, V.N.; Nkegoum, B.; Taziebou, P.C.L.; Tekwu, E.M.; Etoa, F.X.; Ngongang, J. Evaluation of acute and subacute toxicities of aqueous ethanolic extract of leaves of Senna alata (L.) Roxb (Ceasalpiniaceae). Afr. J. Biotechnol. 2006, 5, 283–289. [Google Scholar]
  16. Ajose, F.O. Some Nigerian plants of dermatologic importance. Int. J. Dermatol. 2007, 46, 48–55. [Google Scholar]
  17. Makinde, A.A.; Igoli, J.O.; Ta’Ama, L.; Shaibu, S.J.; Garba, A. Antimicrobial activity of Cassia alata. Afr. J. Biotechnol. 2007, 6, 1509–1510. [Google Scholar]
  18. Villaseñor, I.M.; Canlas, A.P.; Pascua, M.P.I.; Sabando, M.N.; Soliven, L.A.P. Bioactivity studies on Cassia alata Linn. leaf extracts. Phytother. Res. 2002, 16 (Suppl. S1), 93–96. [Google Scholar]
  19. Rahmawati, F.; Prihantini, N.N.; Hady, B.C. In vitro bioactivity test of Senna alata (L.) Roxb leaves extract. Int. J. Health Sci. Res. 2022, 12, 304–317. [Google Scholar]
  20. El-Mahmood, A.; Doughari, J. Phytochemical screening and antibacterial evaluation of the leaf and root extracts of Cassia alata Linn. Afr. J. Pharm. Pharmacol. 2008, 2, 124–129. [Google Scholar]
  21. Eliakim-Ikechukwu, C.F.; Edem, A.A.; William, U.; Okori, S.O.; Ihentuge, C.J. Phytochemical composition of Cassia alata leaf extract and its effect on the histology of the pancreas of diabetic wistar rats. IOSR J. Pharm. Biol. Sci. 2013, 5, 07–13. [Google Scholar]
  22. Sule, W.; Okonko, I.O.; Omo-Ogun, S.; Nwanze, J.; Ojezele, M.O.; Ojezele, O.J.; Adeolu, A.J.; Soyemi, E.T.; Olaonipekun, T.O. Phytochemical properties and in-vitro antifungal activity of Senna alata Linn. crude stem bark extract. J. Med. Plants Res. 2011, 5, 176–183. [Google Scholar]
  23. Hazni, H.; Ahmad, N.; Hitotsuyanagi, Y.; Takeya, K.; Choo, C.-Y. Phytochemical constituents from Cassia alata with inhibition against methicillin-resistant Staphylococcus aureus (MRSA). Planta Med. 2008, 74, 1802–1805. [Google Scholar]
  24. Jain, R.; Chitale, G.; Sharma, P.; Jain, S. Phytochemical and anti-microbial investigations of Cassia alata Linn. roots. J. Med. Aromat. Plant Sci. 2010, 32, 13–15. [Google Scholar]
  25. Mohammed, A.R.; Ali, A.M.; Aboul-Enein, S.M.; Mohamed, F.M.; Abou, E.; Magdy, M.D.; Mohammed, A.R.H. Phytochemical, cytotoxicity and antioxidant investigation of Cassia alata leaves growing in Egypt. J. Innov. Pharm. Biol. Sci. 2017, 4, 97–105. [Google Scholar]
  26. Riaz, A.; Rasul, A.; Hussain, G.; Zahoor, M.K.; Jabeen, F.; Subhani, Z.; Younis, T.; Ali, M.; Sarfraz, I.; Selamoglu, Z. Astragalin: A bioactive phytochemical with potential therapeutic activities. Adv. Pharmacol. Sci. 2018, 2018, 9794625. [Google Scholar]
  27. Lewis, A.; Levy, A. Anti-inflammatory activities of Cassia alata leaf extract in complete Freund’s adjuvant arthritis in rats. West Indian Med. J. 2011, 60, 615–621. [Google Scholar]
  28. Devi, K.P.; Malar, D.S.; Nabavi, S.F.; Sureda, A.; Xiao, J.; Nabavi, S.M.; Daglia, M. Kaempferol and inflammation: From chemistry to medicine. Pharmacol. Res. 2015, 99, 1–10. [Google Scholar]
  29. Wang, J.; Fang, X.; Ge, L.; Cao, F.; Zhao, L.; Wang, Z.; Xiao, W. Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol. PLoS ONE 2018, 13, e0197563. [Google Scholar]
  30. Palanichamy, S.; Nagarajan, S. Anti-inflammatory activity of Cassia alata leaf extract and kaempferol 3-O-sophoroside. Fitoterapia 1990, 61, 44–47. [Google Scholar]
  31. Meenupriya, J.; Vinisha, A.S.; Priya, P. Cassia alata and Cassia auriculata–Review of their bioactive potential. World J. Pharm. Sci. 2014, 2, 1760–1769. [Google Scholar]
  32. Aziz, N.; Kim, M.-Y.; Cho, J.Y. Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies. J. Ethnopharmacol. 2018, 225, 342–358. [Google Scholar]
  33. Nabavi, S.F.; Braidy, N.; Gortzi, O.; Sobarzo-Sanchez, E.; Daglia, M.; Skalicka-Woźniak, K.; Nabavi, S.M. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review. Brain Res. Bull. 2015, 119, 1–11. [Google Scholar]
  34. Jeon, I.H.; Kim, H.S.; Kang, H.J.; Lee, H.-S.; Jeong, S.I.; Kim, S.J.; Jang, S.I. Anti-inflammatory and antipruritic effects of luteolin from Perilla (P. frutescens L.) leaves. Molecules 2014, 19, 6941–6951. [Google Scholar]
  35. Ali, F.; Rahul Naz, F.; Jyoti, S.; Siddique, Y.H. Health functionality of apigenin: A review. Int. J. Food Prop. 2017, 20, 1197–1238. [Google Scholar]
  36. Kim, S.-G.; Choi, J.G.; Jang, Y.-A. Emodin Studies on Anti-inflammatory and Skin Barrier Improvement Activities. J. Korean Appl. Sci. Technol. 2021, 38, 1383–1392. [Google Scholar]
  37. Lu, Y.; Yang, J.H.; Li, X.; Hwangbo, K.; Hwang, S.-L.; Taketomi, Y.; Murakami, M.; Chang, Y.-C.; Kim, C.-H.; Son, J.-K.; et al. Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. Biochem. Pharmacol. 2011, 82, 1700–1708. [Google Scholar]
  38. Dong, X.; Fu, J.; Yin, X.; Cao, S.; Li, X.; Lin, L.; Huyiligeqi; Ni, J. Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics. Phytother. Res. 2016, 30, 1207–1218. [Google Scholar]
  39. Ginwala, R.; Bhavsar, R.; Chigbu, D.G.I.; Jain, P.; Khan, Z.K. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants 2019, 8, 35. [Google Scholar]
  40. Dong, X.; Zeng, Y.; Liu, Y.; You, L.; Yin, X.; Fu, J.; Ni, J. Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics. Phytother. Res. 2020, 34, 270–281. [Google Scholar]
  41. Park, M.-Y.; Kwon, H.-J.; Sung, M.-K. Evaluation of aloin and aloe-emodin as anti-inflammatory agents in aloe by using murine macrophages. Biosci. Biotechnol. Biochem. 2009, 73, 828–832. [Google Scholar]
  42. Hu, B.; Zhang, H.; Meng, X.; Wang, F.; Wang, P. Aloe-emodin from rhubarb (Rheum rhabarbarum) inhibits lipopolysaccharide-induced inflammatory responses in RAW264. 7 macrophages. J. Ethnopharmacol. 2014, 153, 846–853. [Google Scholar]
  43. Mar’ie, A.M.; Zamzani, I.; Nashihah, S. Antibacterial activity of Cassia alata stems ethanol extract against Staphylococcus aureus. Acta Pharm. Indones. 2022, 10, 5462. [Google Scholar]
  44. Chatterjee, S.; Chatterjee, S.; Dutta, S. Cassia alata-An useful anti-microbial agent. Med. Aromat. Plants 2013, 1, e143. [Google Scholar]
  45. Muhammad, S.L.; Wada, Y.; Mohammed, M.; Ibrahim, S.; Musa, K.Y.; Olonitola, O.S.; Ahmad, M.H.; Mustapha, S.; Rahman, Z.A.; Sha’aban, A. Bioassay-guided identification of bioactive compounds from Senna alata L. against methicillin-resistant Staphylococcus aureus. Appl. Microbiol. 2021, 1, 520–536. [Google Scholar]
  46. Breuer, K.; Häussler, S.; Kapp, A.; Werfel, T. Staphylococcus aureus: Colonising features and influence of an antibacterial treatment in adults with atopic dermatitis. Br. J. Dermatol. 2002, 147, 55–61. [Google Scholar]
  47. Chatterjee, S.; Chatterjee, S.; Dey, K.; Dutta, S. Study of antioxidant activity and immune stimulating potency of the ethnomedicinal plant, Cassia alata (L.) Roxb. Med. Aromat. Plants 2013, 2, 131. [Google Scholar] [CrossRef]
  48. Waris, M.A.A.; Farid, A.M. Antifungal activity of Cassia alata L. ethyl acetate and n-hexane leaves extract against Candida albicans. J. Public Health Pharm. 2021, 1, 27–29. [Google Scholar]
  49. Sivaranjani, N.; Rao, S.V.; Rajeev, G. Role of reactive oxygen species and antioxidants in atopic dermatitis. J. Clin. Diagn. Res. JCDR 2013, 7, 2683–2685. [Google Scholar]
  50. Chua, L.Y.W.; Figiel, A.; Chong, C.H.; Wojdyło, A.; Szumny, A.; Lech, K. Characterisation of the convective hot-air drying and vacuum microwave drying of Cassia alata: Antioxidant activity, essential oil volatile composition and quality studies. Molecules 2019, 24, 1625. [Google Scholar]
  51. Fatmawati, S.; Purnomo, A.S.; Bakar, M.F.A. Chemical constituents, usage and pharmacological activity of Cassia alata. Heliyon 2020, 6, e04396. [Google Scholar]
  52. Sagnia, B.; Fedeli, D.; Casetti, R.; Montesano, C.; Falcioni, G.; Colizzi, V. Antioxidant and anti-inflammatory activities of extracts from Cassia alata, Eleusine indica, Eremomastax speciosa, Carica papaya and Polyscias fulva medicinal plants collected in Cameroon. PLoS ONE 2014, 9, e103999. [Google Scholar]
  53. Casetti, F.; Bartelke, S.; Biehler, K.; Augustin, M.; Schempp, C.; Frank, U. Antimicrobial activity against bacteria with dermatological relevance and skin tolerance of the essential oil from Coriandrum sativum L. fruits. Phytother. Res. 2012, 26, 420–424. [Google Scholar]
  54. Sikora, B.C.; Wortzman, M.; Nelson, D.B.; Dover, J.S. A pilot study evaluating the efficacy and tolerability of a comprehensive, hydrating topical antioxidant developed specifically for men. J. Cosmet. Dermatol. 2021, 20, 2816. [Google Scholar]
  55. Midawa, S.; Ali, B.; Mshelia, B.; Johnson, J. Cutaneous wound healing activity of the ethanolic extracts of the leaf of Senna alata L. (fabaceae). J. Biol. Sci. Bioconserv. 2010, 2, 63. [Google Scholar]
  56. Kanedi, M. Healing effect of leaf extract of candlebush (Cassia alata L.) on cutaneous wound infected with Trichophyton rubrum. World J. Pharm. Life Sci. 2016, 2, 42–50. [Google Scholar]
  57. Palanichamy, S.; Bhaskar, E.A.; Bakthavathsalam, R.; Nagarajan, S. Wound healing activity of Cassia alata. Fitoterapia 1991, 62, 153–156. [Google Scholar]
  58. Iraqui, P.; Chakraborty, T.; Das, M.K.; Yadav, R. Herbal anti-microbial gel with leaf extract of Cassia alata L. J. Drug Deliv. Ther. 2019, 9, 82–94. [Google Scholar]
  59. Globinmed. Coriandrum sativum L. 2017 [Updated 13 March 2017]. Available online: https://globinmed.com/index.php?option=com_content&view=article&id=106139:coriandrum-sativum-l&catid=286&Itemid=357 (accessed on 28 June 2021).
  60. Eikani, M.H.; Golmohammad, F.; Rowshanzamir, S. Subcritical water extraction of essential oils from coriander seeds (Coriandrum sativum L.). J. Food Eng. 2007, 80, 735–740. [Google Scholar]
  61. Wangensteen, H.; Samuelsen, A.B.; Malterud, K.E. Antioxidant activity in extracts from coriander. Food Chem. 2004, 88, 293–297. [Google Scholar]
  62. Reuter, J.; Wölfle, U.; Weckesser, S.; Schempp, C. Which plant for which skin disease? Part 1: Atopic dermatitis, psoriasis, acne, condyloma and herpes simplex. J. Dtsch. Dermatol. Ges. 2010, 8, 788–796. [Google Scholar]
  63. Chahal, K.; Singh, R.; Kumar, A.; Bhardwaj, U. Chemical composition and biological activity of Coriandrum sativum L.: A review. Indian J. Nat. Prod. Resour. (IJNPR) [Former. Nat. Prod. Radiance (NPR)] 2018, 8, 193–203. [Google Scholar]
  64. Chawla, S.; Thakur, M. Coriandrum sativum: A promising functional and medicinal food. Med. Plants-Int. J. Phytomed. Relat. Ind. 2013, 5, 59–65. [Google Scholar]
  65. Rajeshwari, U.; Andallu, B. Medicinal benefits of coriander (Coriandrum sativum L). Spatula DD 2011, 1, 51–58. [Google Scholar]
  66. Mandal, S.; Mandal, M. Coriander (Coriandrum sativum L.) essential oil: Chemistry and biological activity. Asian Pac. J. Trop. Biomed. 2015, 5, 421–428. [Google Scholar]
  67. Sonika, G.; Manubala, R.; Deepak, J. Comparative studies on anti-inflammatory activity of Coriandrum sativum, Datura stramonium and Azadirachta indica. Asian J. Exp. Biol. Sci. 2010, 1, 151–154. [Google Scholar]
  68. Park, G.; Kim, H.G.; Lim, S.; Lee, W.; Sim, Y.; Oh, M.S. Coriander alleviates 2, 4-dinitrochlorobenzene-induced contact dermatitis-like skin lesions in mice. J. Med. Food 2014, 17, 862–868. [Google Scholar]
  69. Malek Mahdavi, A.; Javadivala, Z. Systematic review of preclinical studies about effects of Coriandrum sativum L. on inflammatory mediators. Inflammopharmacology 2022, 30, 1131–1141. [Google Scholar]
  70. Trifan, A.; Luca, S.V.; Bostănaru, A.-C.; Brebu, M.; Jităreanu, A.; Cristina, R.-T.; Skalicka-Woźniak, K.; Granica, S.; Czerwińska, M.E.; Kruk, A.; et al. Apiaceae essential oils: Boosters of terbinafine activity against dermatophytes and potent anti-inflammatory effectors. Plants 2021, 10, 2378. [Google Scholar]
  71. Koppula, S.; Alluri, R.; Kopalli, S.R. Coriandrum sativum attenuates microglia mediated neuroinflammation and MPTP-induced behavioral and oxidative changes in Parkinson’s disease mouse model. EXCLI J. 2021, 20, 835. [Google Scholar]
  72. Yuan, R.; Liu, Z.; Zhao, J.; Wang, Q.-Q.; Zuo, A.; Huang, L.; Gao, H.; Xu, Q.; Khan, I.A.; Yang, S. Novel compounds in fruits of coriander (Coşkuner & Karababa) with anti-inflammatory activity. J. Funct. Foods 2020, 73, 104145. [Google Scholar]
  73. Nan, L.; Lee, C.-H.; Choi, Y.-N.; Choo, B.-K. Anti-oxidant and anti-inflammatory effects of ethanol extracts from aerial part of Coriandrum sativum L. Korean J. Org. Agric. 2019, 27, 513–528. [Google Scholar]
  74. Raveau, R.; Fontaine, J.; Verdin, A.; Mistrulli, L.; Laruelle, F.; Fourmentin, S.; Sahraoui, A.L.-H. Chemical composition, antioxidant and anti-inflammatory activities of clary sage and coriander essential oils produced on polluted and amended soils-phytomanagement approach. Molecules 2021, 26, 5321. [Google Scholar]
  75. Jia, H.; Wen, Y.; Aw, W.; Saito, K.; Kato, H. Ameliorating effects of coriander on gastrocnemius muscles undergoing precachexia in a rat model of rheumatoid arthritis: A proteomics analysis. Nutrients 2021, 13, 4041. [Google Scholar]
  76. Deepa, B.; Acharya, S.; Holla, R. Evaluation of antiarthritic activity of coriander seed essential oil in Wistar albino rats. Res. J. Pharm. Technol. 2020, 13, 761–766. [Google Scholar]
  77. Ouyang, L.; Dan, Y.; Shao, Z.; Yang, S.; Yang, C.; Liu, G.; Zhou, W.; Duan, D. Effect of umbelliferone on adjuvant-induced arthritis in rats by MAPK/NF-κB pathway. Drug Des. Devel. Ther. 2019, 13, 1163. [Google Scholar]
  78. Kükner, A.; Soyler, G.; Toros, P.; Dede, G.; Meriçli, F.; Işık, S.; Edebal, O.; Özoğul, C. Protective effect of Coriandrum sativum extract against inflammation and apoptosis in liver ischaemia/reperfusion injury. Folia Morphol. (Praha) 2021, 80, 363–371. [Google Scholar]
  79. Qosimah, D.; Widyarti, S.; Mag, B.; Rifa’i, M. Improved cellular immunity and increased insulin in streptozotos-ininduced mice using ethanol coriander (Coriandrum sativum) extract. Res. J. Pharm. Technol. 2021, 14, 3689–3694. [Google Scholar]
  80. Kajal, A.; Singh, R. Coriandrum sativum improve neuronal function via inhibition of oxidative/nitrosative stress and TNF-α in diabetic neuropathic rats. J. Ethnopharmacol. 2020, 263, 112959. [Google Scholar]
  81. Hassanen, N.H.; Eissa, A.; Hafez, S.; Mosa, E.A. Antioxidant and anti-microbial activity of celery (Apium graveolens) and coriander (Coriandrum sativum) herb and seed essential oils. Int. J. Curr. Microbiol. App. Sci. 2015, 4, 284–296. [Google Scholar]
  82. Afrin, S.; Goswami, B.; Rahman, S.; Bhuiyan, M.N.I.; Shamima, K.A.A.; Nandi, N.C. Anti-microbial potential of Coriandrum sativum, Lactuca sativa and Mentha spicata against antibiotic resistant microorganisms. J. Herbs Spices Med. Plants 2022, 28, 193–205. [Google Scholar]
  83. Mazaher Ghorbani, M.; Ahmady-Asbchin, S. Evaluation of antibacterial properties of coriander, oregano, fennel, thyme and parsley extracts, on pathogenic bacteria Staphylococcus aureus (ATCC 33591), Escherichia coli (ATCC 23591), Klebsiella (ATCC 10031) and Salmonella typhimurium. J. Sabzevar Univ. Med. Sci. 2018, 25, 591–598. [Google Scholar]
  84. de Almeida Melo, E.; Mancini Filho, J.; Guerra, N.B. Characterisation of antioxidant compounds in aqueous coriander extract (Coriandrum sativum L.). LWT-Food Sci. Technol. 2005, 38, 15–19. [Google Scholar]
  85. Guerra, N.B.; de Almeida Melo, E.; Mancini Filho, J. Antioxidant compounds from coriander (Coriandrum sativum L.) etheric extract. J. Food Compost. Anal. 2005, 18, 193–199. [Google Scholar]
  86. Kačániová, M.; Galovičová, L.; Ivanišová, E.; Vukovic, N.L.; Štefániková, J.; Valková, V.; Borotová, P.; Žiarovská, J.; Terentjeva, M.; Felšöciová, S.; et al. Antioxidant, antimicrobial and antibiofilm activity of coriander (Coriandrum sativum L.) essential oil for its application in foods. Foods 2020, 9, 282. [Google Scholar]
  87. Msaada, K.; Ben Jemia, M.; Salem, N.; Bachrouch, O.; Sriti, J.; Tammar, S.; Bettaieb, I.; Jabri, I.; Kefi, S.; Limam, F.; et al. Antioxidant activity of methanolic extracts from three coriander (Coriandrum sativum L.) fruit varieties. Arab. J. Chem. 2017, 10, S3176–S3183. [Google Scholar]
  88. Ashraf, I.; Zubair, M.; Rizwan, K.; Rasool, N.; Jamil, M.; Khan, S.A.; Tareen, R.B.; Ahmad, V.U.; Mahmood, A.; Riaz, M.; et al. Chemical composition, antioxidant and anti-microbial potential of essential oils from different parts of Daphne mucronata Royle. Chem. Cent. J. 2018, 12, 1–8. [Google Scholar]
  89. Hajlaoui, H.; Arraouadi, S.; Noumi, E.; Aouadi, K.; Adnan, M.; Khan, M.A.; Kadri, A.; Kadri, M. Antimicrobial, antioxidant, anti-acetylcholinesterase, antidiabetic, and pharmacokinetic properties of Carum carvi L. and Coriandrum sativum L. essential oils alone and in combination. Molecules 2021, 26, 3625. [Google Scholar]
  90. Shahwar, M.K.; El-Ghorab, A.H.; Anjum, F.M.; Butt, M.S.; Hussain, S.; Nadeem, M. Characterization of coriander (Coriandrum sativum L.) seeds and leaves: Volatile and non volatile extracts. Int. J. Food Prop. 2012, 15, 736–747. [Google Scholar]
  91. Zadeh, A.; Mahzooni, T.; Emami, S.A.; Akbari, H.; Fatemi, M.J.; Saberi, M.; Bagheri, T.; Niazi, M.; Araghi, S. The effect of Coriander cream on healing of superficial second degree burn wound. Tehran Univ. Med. J. 2015, 73, 646–652. [Google Scholar]
  92. Hwang, E.; Lee, D.-G.; Park, S.H.; Oh, M.S.; Kim, S.Y. Coriander leaf extract exerts antioxidant activity and protects against UVB-induced photoaging of skin by regulation of procollagen type I and MMP-1 expression. J. Med. Food 2014, 17, 985–995. [Google Scholar]
  93. Silva, J.R.; Burger, B.; Kühl, C.; Candreva, T.; Dos Anjos, M.B.; Rodrigues, H.G. Wound healing and omega-6 fatty acids: From inflammation to repair. Mediat. Inflamm. 2018, 2018, 2503950. [Google Scholar]
  94. Ashraf, K. A comprehensive review on Curcuma longa Linn.: Phytochemical, pharmacological, and molecular study. Int. J. Green Pharm. (IJGP) 2018, 11, S671–S685. [Google Scholar] [CrossRef]
  95. Afaq, F.; Adhami, V.M.; Ahmad, N.; Mukhtar, H. Botanical antioxidants for chemoprevention of photocarcinogenesis. Front Biosci. 2002, 7, d784–d792. [Google Scholar]
  96. Priyadarsini, K.I. The chemistry of curcumin: From extraction to therapeutic agent. Molecules 2014, 19, 20091–20112. [Google Scholar]
  97. Ashraf, K.; Mujeeb, M.; Ahmad, A.; Amir, M.; Mallick, M.N.; Sharma, D. Validated HPTLC analysis method for quantification of variability in content of curcumin in Curcuma longa L (turmeric) collected from different geographical region of India. Asian Pac. J. Trop. Biomed. 2012, 2, S584–S588. [Google Scholar]
  98. Pandeya, N. Old wives’ tales: Modern miracles—turmeric as traditional medicine in India. Trees Life J. 2005, 1, 3. [Google Scholar]
  99. Tilak, J.C.; Banerjee, M.; Mohan, H.; Devasagayam, T. Antioxidant availability of turmeric in relation to its medicinal and culinary uses. Phytother. Res. 2004, 18, 798–804. [Google Scholar]
  100. Govindarajan, V.; Stahl, W.H. Turmeric—chemistry, technology, and quality. Crit. Rev. Food Sci. Nutr. 1980, 12, 199–301. [Google Scholar]
  101. Nelson, K.M.; Dahlin, J.L.; Bisson, J.; Graham, J.; Pauli, G.F.; Walters, M.A. The essential medicinal chemistry of curcumin: Miniperspective. J. Med. Chem. 2017, 60, 1620–1637. [Google Scholar]
  102. Kapoor, L. CRC Handbook of Ayurvedic Medicinal Plants; CRC Press: Boca Raton, FL, USA, 2018. [Google Scholar]
  103. Kumar, N.; Sakhya, S.K. Ethnopharmacological properties of Curcuma longa: A review. Int. J. Pharm. Sci. Res. 2013, 4, 103. [Google Scholar]
  104. Bundy, R.; Walker, A.F.; Middleton, R.W.; Booth, J. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: A pilot study. J. Altern. Complement. Med. 2004, 10, 1015–1018. [Google Scholar]
  105. Singh, S.; Aggarwal, B.B. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)(∗). J. Biol. Chem. 1995, 270, 24995–25000. [Google Scholar]
  106. Razavi, B.M.; Ghasemzadeh Rahbardar, M.; Hosseinzadeh, H. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytother. Res. 2021, 35, 6489–6513. [Google Scholar]
  107. Choi, Y.; Park, K.Y.; Han, H.S.; Lee, M.-K.; Seo, S.J. Comparative Analysis of Cutaneous Fungi in Atopic Dermatitis Patients and Healthy Individuals. Ann. Dermatol. 2022, 34, 118. [Google Scholar]
  108. Rasmussen, H.B.; Christensen, S.B.; Kvist, L.P.; Karazmi, A. A simple and efficient separation of the curcumins, the antiprotozoal constituents of Curcuma longa. Planta Med. 2000, 66, 396–398. [Google Scholar]
  109. Khattak, S.; Shah, H.U.; Ahmad, W.; Ahmad, M. Biological effects of indigenous medicinal plants Curcuma longa and Alpinia galanga. Fitoterapia 2005, 76, 254–257. [Google Scholar]
  110. Parveen, Z.; Nawaz, S.; Siddique, S.; Shahzad, K. Composition and anti-microbial activity of the essential oil from leaves of Curcuma longa L. Kasur variety. Indian J. Pharm. Sci. 2013, 75, 117. [Google Scholar]
  111. Apisariyakul, A.; Vanittanakom, N.; Buddhasukh, D. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J. Ethnopharmacol. 1995, 49, 163–169. [Google Scholar]
  112. Hussain, Y.; Alam, W.; Ullah, H.; Dacrema, M.; Daglia, M.; Khan, H.; Arciola, C.R. Anti-microbial potential of curcumin: Therapeutic potential and challenges to clinical applications. Antibiotics 2022, 11, 322. [Google Scholar]
  113. Chittasupho, C.; Manthaisong, A.; Okonogi, S.; Tadtong, S.; Samee, W. Effects of quercetin and curcumin combination on antibacterial, antioxidant, in vitro wound healing and migration of human dermal fibroblast cells. Int. J. Mol. Sci. 2021, 23, 142. [Google Scholar]
  114. Girish, C.; Koner, B.C.; Jayanthi, S.; Ramachandra Rao, K.; Rajesh, B.; Pradhan, S.C. Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice. Fundam. Clin. Pharmacol. 2009, 23, 735–745. [Google Scholar]
  115. Selvam, R.; Subramanian, L.; Gayathri, R.; Angayarkanni, N. The anti-oxidant activity of turmeric (Curcuma longa). J. Ethnopharmacol. 1995, 47, 59–67. [Google Scholar]
  116. Smitha, S.; Dhananjaya, B.; Dinesha, R.; Srinivas, L. Purification and characterisation of a∼ 34 kDa antioxidant protein (β-turmerin) from turmeric (Curcuma longa) waste grits. Biochimie 2009, 91, 1156–1162. [Google Scholar]
  117. Sugiyama, Y.; Kawakishi, S.; Osawa, T. Involvement of the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem. Pharmacol. 1996, 52, 519–525. [Google Scholar]
  118. Patel, N.A.; Patel, M.; Patel, R.P. Formulation and evaluation of polyherbal gel for wound healing. Int. Res. J. Pharm. 2011, 1, 15–20. [Google Scholar]
  119. Kulac, M.; Aktas, C.; Tulubas, F.; Uygur, R.; Kanter, M.; Erboga, M.; Ceber, M.; Topcu, B.; Ozen, O.A. The effects of topical treatment with curcumin on burn wound healing in rats. J. Mol. Histol. 2013, 44, 83–90. [Google Scholar]
  120. Maghimaa, M.; Alharbi, S.A. Green synthesis of silver nanoparticles from Curcuma longa L. and coating on the cotton fabrics for anti-microbial applications and wound healing activity. J. Photochem. Photobiol. B Biol. 2020, 204, 111806. [Google Scholar]
  121. Bhutta, Z.A.; Ashar, A.; Mahfooz, A.; Khan, J.A.; Saleem, M.I.; Rashid, A.; Aqib, A.I.; Kulyar, M.F.-E.; Sarwar, I.; Shoaib, M.; et al. Enhanced wound healing activity of nano ZnO and nano Curcuma longa in third-degree burn. Appl. Nanosci. 2021, 11, 1267–1278. [Google Scholar]
  122. Benelli, G.; Caselli, A.; Di Giuseppe, G.; Canale, A. Control of biting lice, Mallophaga—A review. Acta Trop. 2018, 177, 211–219. [Google Scholar]
  123. Alzohairy, M.A. Therapeutics role of Azadirachta indica (Neem) and their active constituents in diseases prevention and treatment. Evid. Based Complement. Altern. Med. 2016, 2016, 7382506. [Google Scholar]
  124. Asif, M. Antimicrobial potential of Azadirachta indica against pathogenic bacteria and fungi. J. Pharmacogn. Phytochem. 2012, 1, 78–83. [Google Scholar]
  125. Chattopadhyay, R. Possible biochemical mode of anti-inflammatory action of Azadirachta indica A. Juss. in rats. Indian J. Exp. Biol. 1998, 36, 418–420. [Google Scholar]
  126. Mosaddek, A.S.M.; Rashid, M.M.U. A comparative study of the anti-inflammatory effect of aqueous extract of neem leaf and dexamethasone. Bangladesh J. Pharmacol. 2008, 3, 44–47. [Google Scholar]
  127. Pandey, S.; Jha, A.; Kaur, V. Aqueous extract of neem leaves in treatment of Psoriasis vulgaris. Indian J. Dermatol. Venereol. Leprol. 1994, 60, 63–67. [Google Scholar]
  128. Kaur, G.; Sarwar Alam, M.; Athar, M. Nimbidin suppresses functions of macrophages and neutrophils: Relevance to its antiinflammatory mechanisms. Phytother. Res. 2004, 18, 419–424. [Google Scholar]
  129. Naik, M.R.; Bhattacharya, A.; Behera, R.; Agrawal, D.; Dehury, S.; Kumar, S. Study of anti-inflammatory effect of neem seed oil (Azadirachta indica) on infected albino rats. J. Health Res. Rev. 2014, 1, 66. [Google Scholar]
  130. Ilango, K.; Maharajan, G.; Narasimhan, S. Anti-nociceptive and anti-inflammatory activities of Azadirachta indica fruit skin extract and its isolated constituent azadiradione. Nat. Prod. Res. 2013, 27, 1463–1467. [Google Scholar]
  131. Raut, R.R.; Sawant, A.R.; Jamge, B.B. Anti-microbial activity of Azadirachta indica (Neem) against pathogenic microorganisms. J. Acad. Ind. Res. 2014, 3, 327–329. [Google Scholar]
  132. Patankar, R.S.; Chandak, N. Formulation of herbal sanitisers and determining their anti-microbial activities against skin pathogens. Int. J. Innov. Sci. Res. Technol. 2018, 3, 169–177. [Google Scholar]
  133. Lakshmi, T.; Krishnan, V.; Rajendran, R.; Madhusudhanan, N. Azadirachta indica: A herbal panacea in dentistry–An update. Pharmacogn. Rev. 2015, 9, 41. [Google Scholar]
  134. Airaodion, A.I.; Olatoyinbo, P.O.; Ogbuagu, U.; Ogbuagu, E.O.; Akinmolayan, J.D.; Adekale, O.A.; Awosanya, O.O.; Agunbiade, A.P.; Oloruntoba, A.P.; Obajimi, O.O.; et al. Comparative assessment of phytochemical content and antioxidant potential of Azadirachta indica and Parquetina nigrescens leaves. Asian Plant Res. J. 2019, 2, 1–14. [Google Scholar]
  135. Bertino, L.; Guarneri, F.; Cannavò, S.P.; Casciaro, M.; Pioggia, G.; Gangemi, S. Oxidative stress and atopic dermatitis. Antioxidants 2020, 9, 196. [Google Scholar]
  136. Pokhrel, B.; Rijal, S.; Raut, S.; Pandeya, A. Investigations of antioxidant and antibacterial activity of leaf extracts of Azadirachta indica. Afr. J. Biotechnol. 2015, 14, 3159–3163. [Google Scholar]
  137. Sultana, B.; Anwar, F.; Przybylski, R. Antioxidant activity of phenolic components present in barks of Azadirachta indica, Terminalia arjuna, Acacia nilotica, and Eugenia jambolana Lam. trees. Food Chem. 2007, 104, 1106–1114. [Google Scholar]
  138. Barua, C.; Talukdar, A.; Barua, A.; Chakraborty, A.; Sarma, R.; Bora, R. Evaluation of the wound healing activity of methanolic extract of Azadirachta indica (Neem) and Tinospora cordifolia (Guduchi) in rats. Pharmacologyonline 2010, 1, 70–77. [Google Scholar]
  139. Manca, M.; Manconi, M.; Meloni, M.; Marongiu, F.; Allaw, M.; Usach, I.; Peris, J.; Escribano-Ferrer, E.; Tuberoso, C.; Gutierrez, G.; et al. Nanotechnology for natural medicine: Formulation of neem oil loaded phospholipid vesicles modified with argan oil as a strategy to protect the skin from oxidative stress and promote wound healing. Antioxidants 2021, 10, 670. [Google Scholar]
  140. Osunwoke Emeka, A.; Olotu Emamoke, J.; Allison Theodore, A.; Onyekwere Julius, C. The wound healing effects of aqueous leave extracts of Azadirachta indica on wistar rats. J. Nat. Sci. Res. 2013, 3, 181–186. [Google Scholar]
Molecules 27 05475 g001 550
Figure 1. Cassia alata plant.
Figure 1. Cassia alata plant.
Molecules 27 05475 g001
Molecules 27 05475 g002 550
Figure 2. Coriandrum sativum plant and seeds.
Figure 2. Coriandrum sativum plant and seeds.
Molecules 27 05475 g002
Molecules 27 05475 g003 550
Figure 3. Curcuma longa rhizomes.
Figure 3. Curcuma longa rhizomes.
Molecules 27 05475 g003
Molecules 27 05475 g004 550
Figure 4. Azadirachta indica plant.
Figure 4. Azadirachta indica plant.
Molecules 27 05475 g004
Table
Table 1. Types of complementary and alternative medicine (CAM) used in children with AD at a tertiary care centre a. Reproduced from Koo, Nagayah, Begum, Mahmood, and Shah [10].
Table 1. Types of complementary and alternative medicine (CAM) used in children with AD at a tertiary care centre a. Reproduced from Koo, Nagayah, Begum, Mahmood, and Shah [10].
Types of CAMPercentages (%)
CAM user46.8
Traditional Malay Medicine
Malay herbs13.9
Malay massage0.6
Malay cupping0.6
Traditional Chinese Medicine
Chinese herbs5.8
Islamic Medical Practice
Ruqyah16.2
Homoeopathy9.2
Chiropractic0.6
Complementary Therapy
Spa therapy0.6
Aromatherapy1.7
Nutritional therapy b9.8
Others35.3
Virgin coconut oil11.0
Vitamin C9.2
Olive oil6.4
Prebiotic/Probiotic2.3
Remdii™ c2.3
Oiling d1.7
Multivitamin1.2
Omega oil1.2
Blackseed oil1.2
Redoxamin e1.2
Cetaphil® f1.2
Honey1.2
Others g11.6
a Child may have used more than one form of CAM b Nutritional therapy includes organic diet, diet control, gluten-free, and avoidance of dairy food. c Remdii™—tocotrienol-enriched cream. d Oiling—any forms of oil not stated by the parents. e Redoxamin—a product that contains pineapple juice mixed with vitamin C and bromelain. f Cetaphils®—proven dermatological skincare. g Others include Scott’s®, 4Life®, Elken™, Amway™, Yakult® (probiotic drink), Caliph™ (mix fruit extract drink), Al-Manna (Arabic gum), air zamzam (mineral water), ColoSkim by Zhulian™ (skim milk and colostrum mix), turmeric, cendawan kering (dry mushrooms), kurma kering (dry dates), hypoallergenic shampoo/shower, vaseline, aloe vera, CeraVe® cream, Skin Ease® cream, DIY Shea Butter, Nano Colloidal Silver (solution containing nanometre sized particles of suspended silver), herbal cream.
Table
Table 2. Anti-inflammatory activities of astragalin in vitro and in vivo. Reproduced from Riaz et al. [26]. Table reproduced is under Creative Commons Attribution License.
Table 2. Anti-inflammatory activities of astragalin in vitro and in vivo. Reproduced from Riaz et al. [26]. Table reproduced is under Creative Commons Attribution License.
AssaysOrganism TestedDose/ConcentrationMolecular Targets
LPS-induced mouse mastitisMouse mastitis10, 25 and 50 mg/kgTNF-α ↓, IL-1β ↓, IL-6 ↓, p65 ┴, and IκBα ┴
LPS-induced endotozemia and lung injury in miceMice (lung)25, 50, and
75 mg/kg		TNF-α ┴, IL-1β ┴, and IL-6 ┴
LPS-induced macrophages in miceMouse cells1–100 μg/mLIL-6 ↓, MIP-1α ↓, MCP-1 ↓, NF-κB
p65 ┴, IκBα ┴, and NO ┴
LPS-induced RAW 264.7 cellsMice (RAW 264.7 cells)1, 10, and 100 μMNO ↓ and TNF-α ↓
Inhibitory activity on the histamine release by KU812 cellsKU812 cells10 to 30 μmol/LIL-4 ↓, IL-13 ↓, and (IFN- γ) no
effect
LPS-induced
Inflammation in RAW 264.7 cells		Mice (RAW 264.7 cells) NO ┴, IL-6 ┴, and PGE2 ┴
Porphyromonasgingivalis-induced human
gingival epithelial (HGE) cells		Human gingival epithelial cells COX-2 ┴, IL-6 ┴, IL-8 ┴, MMP-1 ┴,
MMP-3 ┴, PGE-2 ┴, and IL-4 ┴
Anti-inflammatory effects on
Leptospira interrogans-induced
inflammatory response		Uterine and endometrial
epithelial cells of mice		100 μg/mLp38 ┴, p-p38 MAPK ↓, ERK ┴, JNK ┴,
and p-p65 ↓
Protective effects against
ovalbumin- (OVA-) induced
allergic inflammation		Mouse model of allergic asthma0.5 mg/kg and
1 mg/kg		SOCS-3 ┴, SOCS-5 ┴, and IFN- γ ↑
Alleviation in hepatic fibrosis
function		Diabetic rats and nondiabetic PAR2 ┴, IL-1β ↓, IL-6 ↓, TNF-α ↓,
and TGF-β1 ┴
Prevention of atopic dermatitisNC/Nga mice1.5 mg/kgIgE ↓
↑ Upregulation; ↓ downregulation; ┴ inhibition.
Table
Table 3. Composition variation of essential oil from various parts of C. sativum.
Table 3. Composition variation of essential oil from various parts of C. sativum.
Plant PartsCompoundsPercentage Composition
SeedsLinalool58.0–80.3
γ-terpinene0.3–11.2
α-pinene0.2–10.9
p-cymene0.1–8.1
Camphor3.0–5.1
Geranyl acetate0.2–5.4
FlowerBenzofuran,2,3-dihydro15.4
Hexadecanoic acid, methyl ester10.32
2,4a-epioxy-3,4,5,6,7,8,-hexahydro-2,5,5,8a-tetramethyl-2h-1-benzofuran9.35
2-methoxy-4-vinylphenol8.8
2,3,5,6-tetrafluroanisole8.62
2,6-dimethyl-3- aminobenzoquinone6.81
Dodecanoic acid5%
LeavesDecanal19.09
Trans-2-decenal17.54
2-decen-1-ol12.33
Cyclodecane12.15
Cis-2-dodecena10.72
Dodecanal4.1
Dodecan-1-ol3.13
Information in the table was adapted from Mandal et al. [66].
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chew, Y.-L.; Khor, M.-A.; Xu, Z.; Lee, S.-K.; Keng, J.-W.; Sang, S.-H.; Akowuah, G.A.; Goh, K.W.; Liew, K.B.; Ming, L.C. Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food Ingredients as Complementary and Alternative Therapies for Atopic Dermatitis-A Comprehensive Review. Molecules 2022, 27, 5475. https://doi.org/10.3390/molecules27175475

AMA Style

Chew Y-L, Khor M-A, Xu Z, Lee S-K, Keng J-W, Sang S-H, Akowuah GA, Goh KW, Liew KB, Ming LC. Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food Ingredients as Complementary and Alternative Therapies for Atopic Dermatitis-A Comprehensive Review. Molecules. 2022; 27(17):5475. https://doi.org/10.3390/molecules27175475

Chicago/Turabian Style

Chew, Yik-Ling, Mei-Ann Khor, Zhao Xu, Sue-Kei Lee, Jing-Wen Keng, Sze-Huey Sang, Gabriel Akyirem Akowuah, Khang Wen Goh, Kai Bin Liew, and Long Chiau Ming. 2022. "Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food Ingredients as Complementary and Alternative Therapies for Atopic Dermatitis-A Comprehensive Review" Molecules 27, no. 17: 5475. https://doi.org/10.3390/molecules27175475

Article Metrics

Back to TopTop